NFKB1 and neoplasm: Non-steroidal anti-inflammatory drugs (NSAIDs) such as aspirin have been shown to suppress NF-κB, which controls the expression of genes such as cyclooxygenase (COX)-2 and cyclin D1, leading to the inhibition of proliferation of tumor cells [114,180].